The second Trump administration threw a landmark anti-money laundering law into limbo in early 2025. Almost a year later, the fate of the Corporate Transparency Act is as clear as mud.
Congress passed CTA with bipartisan support in the final days of President Donald Trump’s first term. Just four years later, the Trump Treasury Department spiked the law’s implementation by announcing that a revamped, narrower rule would only focus on “foreign” companies and exempt American ones.
Presented by AstraZeneca
The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.
Presented by AstraZeneca
The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.
You're subscribed! Welcome to the community.
